FIGURE

Fig. 5

ID

ZDB-FIG-060718-6

Publication

Koppen et al., 2006 - Coordinated cell-shape changes control epithelial movement in zebrafish and Drosophila

Other Figures

All Figure Page

Back to All Figure Page

Fig. 5

Treatment with the myosin 2 inhibitor blebbistatin decreases actin recruitment in the YSL and slows the rate of EVL epiboly.(A,B) Bright-field image of an untreated embryo at bud stage (A) and a (±)-blebbistatin-treated embryo (B). (C) Quantification of epiboly defects resulting from blebbistatin treatments. Shown are the percentages of embryos displaying delayed epiboly (80-95% epiboly) when untreated embryos had reached the 100% epiboly stage. Numbers are based on two independent experiments. Abbreviations: co, untreated control; (+)Blb, (+)-blebbistatin treatment; (±)Blb, (±)-blebbistatin treatment. (D,E) Phalloidin (F-actin) staining of a control embryo at 75% epiboly and a (±)-blebbistatin-treated embryo. (F,G) Phalloidin staining of an untreated embryo at 90% epiboly (F) and (±)-blebbistatin-treated embryo (G), both injected with a morpholino against half baked/E-cadherin. Scale bars: in B, 100 μm for A,B; in E, 50 μm for D,E; in G, 25 μm for F,G.

Expression Data

Expression Detail

Antibody Labeling

Phenotype Data

Phenotype Detail

Acknowledgments

This image is the copyrighted work of the attributed author or publisher, and ZFIN has permission only to display this image to its users. Additional permissions should be obtained from the applicable author or publisher of the image. Full text @ Development